Acrongenomics

Acrongenomics, Molecular Vision on track to meet targets for BioLED technology

Published in Health Insurance Week, September 3rd, 2006

Acrongenomics, Inc., (AGNM) and Molecular Vision, Ltd., presented a research and development update of their joint collaboration, following the meeting of the project's steering committee, that took place recently at Molecular Vision's site in London.

The two companies envisage accelerating the development and commercialization of low-cost, easy-to-use and readily portable Point-of-Care (POC) diagnostic devices. Initial devices will enable personalized on-the-spot monitoring for diabetes management and diagnosis of STDs (Sexually Transmitted Diseases), cardiovascular diseases and substances of abuse, based on the unique BioLED technology platform.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Insurance Week

Source: Health Insurance Week (2006-09-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry